Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10873481 | 0.81 | ALDH1A1 (0.30) | ALDH1A1DPP4 | |
| SCHEMBL2049203 | 0.78 | ALDH1A1 (0.31) | ALDH1A1DPP4 | |
| SCHEMBL9718368 | 0.77 | MAPT (0.32) | — | |
| SCHEMBL5613538 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL5270865 | 0.74 | — | — | |
| SCHEMBL9254464 | 0.74 | — | — | |
| SCHEMBL9283375 | 0.71 | — | — | |
| SCHEMBL5955613 | 0.71 | RAB9A (0.36) | ALDH1A1DPP4 | |
| SCHEMBL22267414 | 0.70 | — | — | |
| SCHEMBL3861415 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9993500-B2 | Proton-binding polymers for oral administration | TRICIDA, INC. (US) | 2018-06-12 | — | — | US | claimed |
| US-9205107-B2 | Proton-binding polymers for oral administration | TRICIDA, INC. (US) | 2015-12-08 | — | — | US | claimed |
| US-11992501-B2 | Compositions for and methods of treating acid-base disorders | RENOSIS, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| US-11986490-B2 | Compositions for and method of treating acid-base disorders | RENOSIS, INC. (US) | 2024-05-21 | — | — | US | disclosed |
| US-20230405043-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | RENIBUS THERAPEUTICS, INC. | 2023-12-21 | — | — | US | disclosed |
| US-11738041-B2 | Proton-binding polymers for oral administration | RENOSIS, INC. (US) | 2023-08-29 | — | — | US | disclosed |
| US-20230031665-A1 | COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS | RENIBUS THERAPEUTICS, INC. | 2023-02-02 | — | — | US | disclosed |
| US-11311571-B2 | Proton-binding polymers for oral administration | TRICIDA, INC. (US) | 2022-04-26 | — | — | US | disclosed |
| US-11197887-B2 | Proton-binding polymers for oral administration | TRICIDA, INC. (US) | 2021-12-14 | — | — | US | disclosed |
| US-20210347925-A1 | CROSSLINKED POLY(ALLYLAMINE) POLYMER PHARMACEUTICAL COMPOSITIONS | RENIBUS THERAPEUTICS, INC. | 2021-11-11 | — | — | US | disclosed |
| US-20210187011-A1 | METHOD OF TREATING ACID-BASE DISORDERS | RENIBUS THERAPEUTICS, INC. | 2021-06-24 | — | — | US | disclosed |
| US-9925214-B2 | Proton-binding polymers for oral administration | TRICIDA, INC. (US) | 2018-03-27 | — | — | US | disclosed |
| EP-3287133-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | Tricida Inc. (US) | 2018-02-28 | — | — | EP | disclosed |
| US-20180021370-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | RENIBUS THERAPEUTICS, INC. | 2018-01-25 | — | — | US | disclosed |
| US-20180015121-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | RENIBUS THERAPEUTICS, INC. | 2018-01-18 | — | — | US | disclosed |
| EP-3003327-B1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | TRICIDA INC (US) | 2017-08-09 | — | — | EP | disclosed |
| US-20160074430-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | RENIBUS THERAPEUTICS, INC. | 2016-03-17 | — | — | US | disclosed |
| US-9205107-B2 | Proton-binding polymers for oral administration | TRICIDA, INC. (US) | 2015-12-08 | — | — | US | disclosed |
| US-20150056451-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | RENIBUS THERAPEUTICS, INC. | 2015-02-26 | — | — | US | disclosed |
| US-5783535-A | MIXTURES CONTAINING CONTROLLED AMOUNTS OF AMIDOETHER CARBOXYLIC ACIDS OR SALTS, AMIDOETHERS, GLYCERINE DERIVATIVES AND CONDITIONERS, FOR SHAMPOO, SKIN CLEANSING FOAM OR DISHWASHING DETERGENT | KAO CORPORATION (JP) | 1998-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11992501-B2 | Compositions for and methods of treating acid-base disorders | SLC10A2, SLC10A1, SLC26A3 | ALDH1A1 1554/4885DPP4 2350/4885 |
| US-20150056451-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | SLC9A1, HRH2, SLC9A2 | ALDH1A1 3400/4885DPP4 3580/4885 |
| US-20160074430-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | SLC9A1, HRH2, SLC9A2 | ALDH1A1 3400/4885DPP4 3580/4885 |
| US-20210187011-A1 | METHOD OF TREATING ACID-BASE DISORDERS | SLC10A2, SLC10A1, SI | ALDH1A1 736/4885DPP4 1518/4885 |
| US-20180021370-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | SLC9A1, HRH2, SLC9A2 | ALDH1A1 3400/4885DPP4 3580/4885 |
| US-20210347925-A1 | CROSSLINKED POLY(ALLYLAMINE) POLYMER PHARMACEUTICAL COMPOSITIONS | PARG, PARN, AAAS | ALDH1A1 779/4885DPP4 2649/4885 |
| US-11738041-B2 | Proton-binding polymers for oral administration | SLC9A1, HRH2, SLC9A2 | ALDH1A1 3400/4885DPP4 3580/4885 |
| US-20230031665-A1 | COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS | SLC10A2, SLC10A1, GLS | ALDH1A1 773/4885DPP4 2545/4885 |
| US-20230405043-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | SLC9A1, HRH2, SLC9A2 | ALDH1A1 3400/4885DPP4 3580/4885 |
| US-11986490-B2 | Compositions for and method of treating acid-base disorders | SLC10A2, SLC10A1, GLS | ALDH1A1 773/4885DPP4 2545/4885 |
| US-20180015121-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | SLC9A1, HRH2, SLC9A2 | ALDH1A1 3400/4885DPP4 3580/4885 |
| US-11311571-B2 | Proton-binding polymers for oral administration | SLC9A1, HRH2, SLC9A2 | ALDH1A1 3400/4885DPP4 3580/4885 |
| US-11197887-B2 | Proton-binding polymers for oral administration | SLC9A1, HRH2, SLC9A2 | ALDH1A1 3400/4885DPP4 3580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.